Clinical Trial Results:
A multicenter, randomized, open-label, phase III clinical trial to compare the efficacy and safety of Ivabradine versus Digoxine in the chronic control of heart rate in patients with permanent atrial fibrillation under treatment with beta-blockers or calcium antagonists.
(IvaBRAdine blocK of funny current for heart rate control in permanEnt Atrial Fibrillation). BRAKE-AF study.
Summary
|
|
EudraCT number |
2018-001936-23 |
Trial protocol |
ES |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
16 Mar 2024
|
First version publication date |
16 Mar 2024
|
Other versions |
|
Summary report(s) |
Clinical Trial Results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.